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Abstract
A recent report in BMC Cell Biology examines how the balance 
of extracellular forces and intracellular contractions regulate the 
shape changes required for oligodendrocyte myelination. A 
failure of remyelination such as seen in multiple sclerosis could 
be caused by loss of this balance.    
       
See related research article http://biomedcentral.com/1471-2121/10/71 
The interplay between intracellular and 
extracellular forces
During development, all cells undergo enormous changes 
in cell shape. After a cell is ‘born’, it migrates to its final 
destination, where it then changes its shape to assume its 
final role. Very often, this involves the formation of cellular 
processes, many of which have specific shapes and 
functions that are characteristic to the individual cell types. 
This process outgrowth and other changes in morphology 
are supported internally by a sturdy network of specialized 
structural proteins that form the cytoskeleton. In addition, 
the surrounding extracellular environment, the extra-
cellular matrix (ECM), mediates the changes in cell shape 
through its mechanical properties. The role of the ECM 
becomes particularly apparent when adherent cells (cells 
that are part of a tissue) are compared with non-adherent 
cells (cells that are floating freely within a liquid, such as 
blood). Although most adherent cells have a very particular 
shape, non-adherent cell types are usually rounded but 
change shape when they attach to surrounding tissue [1], 
suggesting that adherent cells can sense and respond to 
mechanical signals from the ECM.
These mechanosensory properties are mediated by special 
adhesion sites, where the ECM binds to a family of receptor 
proteins within the cell membrane. The most significant of 
these are the integrins. Binding of ECM ligands to 
integrins, with the associated varying degrees of mecha-
nical strain or stretch, promotes the recruitment and 
linkage of part of the cytoskeleton, the actomyosin net-
work, to intracellular integrin domains and thus anchors 
this network at the lipid membrane [2,3]. The actomyosin 
network consists of two major components, actin filaments 
and myosin molecules, which can slide along each other, 
creating an intracellular contractile force (Figure 1a). The 
relationship between this intracellular force and the 
strength of cell adhesion (the extracellular force) could 
then simply regulate shape such that stronger external 
forces would pull the cellular membrane outwards, 
whereas stronger internal forces would maintain a 
rounded shape.
However, cellular events seem to be more complex than 
this. First, recent findings have emphasized the importance 
of functional actomyosin contractile mechanisms for the 
regulation of a wide range of cell properties, including 
tissue formation, cell migration and cell differentiation [4]. 
Second, in contradiction to this simple model, low 
contractile forces generally yield membrane-rich, bulgy cell 
types, whereas strong contractions lead to the formation of 
highly structured cell shapes. Finally, different cell types 
reportedly have different ECM rigidity preferences for the 
induction of their particular shape. All this suggests that 
cellular shapes are determined by a precisely regulated 
interplay of intracellular contractile forces and extra-
cellular attachment.
Interplay of forces in myelination
A particularly striking example of this interplay is the 
neural cell lineage, which gives rise to neurons, astrocytes 
and oligodendrocytes in the central nervous system (CNS). 
Developmentally, all three neural cell types develop from 
the same multipotent stem cells. However, neurons, which 
are generated first, prefer relatively soft surfaces for 
elaboration and branching of axons and dendrites. These 
softer substrates possibly correspond to the environmental 
conditions at the time of initial pathfinding of neuronal 
processes. In contrast, in recently published work in BMC 
Cell Biology [5], Simons and colleagues show that the 
myelin-forming oligodendrocytes that develop later form 
their highly processed morphology and extensive myelin 
sheets best on more rigid surfaces.
This seems logical if we take a closer look at the develop-
mental context of the formation of the insulating myelin 
sheath around axons. Once the migratory oligodendrocyte 
precursor cells (OPCs) have reached their destination and 
start to establish contact with an axon, their processes 
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Figure 1
The role of force in myelination. (a) Molecular force generation. Cells bind ECM components through integrin receptors (represented by α 
and β subunits), thus increasing extracellular adhesion. Integrin activation then triggers signaling cascades involving Fyn kinase, which 
inhibits RhoA, thus activating ROCK and Myosin IIB. Activated Myosin IIB interacts with actin filaments and creates strong intracellular 
contractions, which in turn enhances extracellular attachment and possibly mediates cell differentiation. ECM and cytosol color schemes 
represent the force intensity generated by these molecular events, gray being weakest and red being strongest. (b) Hypothetical effects of 
extracellular rigidity and intracellular contractions. Optimal myelination conditions require a balance between extracellular forces mediated by 
matrix rigidity and intracellular forces based on actomyosin contractions (diagonal arrow). A softer matrix inhibits cell differentiation and 
myelination (shift to the left), which can be counteracted by myosin IIB inhibition (cells return to being balanced). Gliosis, as it occurs in MS, 
might represent a more rigid matrix (shift to the right), which would require stronger contractile forces to counteract.
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change from exploring the unstructured extracellular 
environment of the presumptive myelinated tract, as 
required for migration, to the establishment of close 
contact with the highly structured (and therefore 
probably more rigid) surface of the axon, initiating the 
process of wrapping it with membranous sheets that will 
eventually become the compact myelin sheath [6]. An 
increase in intracellular force would therefore be 
necessary to enable the opposing forces to be matched 
and promote the next stage of oligodendrocyte 
development - the elaborate shape changes that 
accompany myelination (Figure 1b).
The findings of Simons and co-workers [5] also provide 
information about these intracellular mechanisms. Investi-
gation of the role of intracellular contractility in 
differentiation and myelination identified myosin IIB, one 
of the major components of the actomyosin cytoskeleton, 
as a central player in generating intracellular force. In cell 
culture experiments, softer surfaces inhibit process out-
growth, as would be predicted if oligodendrocyte differen-
tiation is normally associated with increased levels of 
intracellular force to match the increased rigidity of the 
axons. This effect can be overcome by pharmacological 
inhibition of myosin IIB, which will reduce intracellular 
contractions and thus better match intracellular force with 
the lower extracellular attachment efficacy provided by less 
rigid substrate (Figure 1b).
These findings are of particular interest for two reasons. 
The first is that they offer a clue as to how one might 
explain the rather surprising reported effects of myosin 
IIB inhibition on myelination in culture. Wang et al. [7] 
showed that myosin IIB inhibition in a neuron-oligo-
dendrocyte co-culture system significantly enhanced the 
formation of the myelin sheath, a change that resulted 
from individual oligodendrocytes forming more 
wrapping processes than cells in untreated control 
cultures. In complete contrast, inhibition of myosin IIB 
in co-cultures of Schwann cells (the myelinating cells of 
the peripheral nervous system) with neurons inhibited 
myelination, and cellular morphology was characterized 
by aberrant process outgrowth. In short, while Schwann 
cells react as would be predicted, oligodendrocytes 
exhibit a behavior that contradicts the conclusions 
obtained from previous experiments. This might reflect 
important differences in the biology of the Schwann cell 
and the oligodendrocyte, in particular in respect to their 
adjustment to in vitro conditions: the extracellular forces 
on the Schwann cell appear to be similar in culture and 
in vivo, whereas the extracellular forces on 
oligodendrocytes in culture are potentially weaker than 
in vivo. The presence of a basal lamina on the non-axonal 
side of the Schwann cell but not the oligodendrocyte both 
in vitro and in vivo might be one means of retaining such 
an extracellular force.
Interplay of forces in multiple sclerosis
The second, and more important, reason for interest in the 
findings of Simons and colleagues [5] is that they offer 
explanations as to why remyelination might fail in the 
demyelinating disease multiple sclerosis (MS) [8]. In MS, 
unknown molecular triggers induce an inflammatory 
reaction in the brain leading to an invasion and activation 
of immune cells (B and T lymphocytes and macrophages) 
and/or the produc tion of antibodies directed against 
myelin components. These events lead to the damage and 
degeneration of the myelin sheath. Remyelination does 
occur in the early stages of the disease as intrinsic 
mechanisms mediate the recruitment of OPCs, which then 
align with the denuded axon and regenerate the sheath. 
However, this repair mechanism eventually fails, for as-yet 
unknown reasons. An implication of the results of Simons 
and colleagues [5] is that increased rigidity in the scarred 
brain may play a role by unbalancing the intracellular and 
extracellular forces and inhibiting oligodendrocyte 
differentiation (Figure 1b).
How might the rigidity of the chronically demyelinated 
CNS be altered? Astrocytes, the third cell type derived from 
the neural lineage, provide nutrients to neurons and 
oligodendrocytes, give biochemical support to the cells 
forming the blood-brain barrier and, in particular, mediate 
the repair and scarring processes in the CNS following 
traumatic injuries. They respond to pathological insults, 
including inflammation and demyelination, with so-called 
reactive gliosis. On a cellular level, this is characterized by 
an upregulation of intermediate filament proteins, leading 
to the formation of a prominent intermediate filament 
network directly underneath the plasma membrane, 
rendering the cellular texture more fibrous [9]. Further-
more, pronounced changes in expression of adhesion 
molecule genes have been described, which would result in 
an altered ECM composition compared with that of initial 
myelination. In demyelinated plaques, reactive astrocytes 
are the most abundant cellular component, and astroglial 
scars have been described as being more rigid than their 
surrounding tissue. These properties might alter force-
sensing integrin function in the oligodendrocyte, unbalan-
cing the cellular forces and inhibiting remyelination.
The main implications of the findings of Simons and 
colleagues [5] are, therefore, that a particular balance of 
extracellular adhesion, matrix rigidity and intracellular 
contractile forces mediated by the oligodendrocyte 
actomyosin cytoskeleton is required for successful 
myelination and remyelination. One interesting prediction 
implied by these data is that extracellular cues that do not 
in themselves alter rigidity, but that do change the activity 
of signaling molecules regulating intracellular force, could 
also inhibit remyelination. As discussed above, the pre-
dominant pathway involved in the signaling mecha nisms 
underlying mechanosensing and mechanotrans duction is 
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binding of ECM ligands to integrin receptors in the 
membrane. The activation of integrins by mechanical forces 
results in the recruitment of intracellular mediators that 
signal through a pathway involving RhoA and its 
downstream effector ROCK to activate force-generating 
myosin II (Figure 1a). The observation that the inhibitory 
effects of myelin debris on OPC differentiation, myelination 
and remyelination are mediated by RhoA-ROCK signaling 
[10] is consistent with this hypothesis [5]. Subsequent 
pharmacological disruption of the ROCK pathway, 
inhibiting myosin IIB and thus actomyosin contractility, 
was able to enhance oligodendrocyte differentiation [10]. 
Clearly, the signaling molecules that regulate intracellular 
force now provide an intriguing source of candidates for 
drug discovery programs aimed at enhancing remyeli nation 
(Figure 1b).
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